Epidermal Growth Factor Receptor Kinase Inhibitor Ameliorates β-Amyloid Oligomer-Induced Alzheimer Disease in Swiss Albino Mice

Alzheimer’s disease (AD) is one of the major neurodegenerative disorders, and its incidence increases globally every year. Currently, available AD drugs symptomatically treat AD with multiple adverse effects. Gefitinib (GE) is an epidermal growth factor receptor (EGFR) kinase inhibitor. EGFR is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhamodharan, Jagadeesh, Sekhar, Ganthimathy, Muthuraman, Arunachalam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412386/
https://www.ncbi.nlm.nih.gov/pubmed/36014421
http://dx.doi.org/10.3390/molecules27165182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412386/
https://www.ncbi.nlm.nih.gov/pubmed/36014421
http://dx.doi.org/10.3390/molecules27165182

Ejemplares similares